LRMR Larimar Therapeutics
- 9.060
- -0.460-4.83%
Larimar Therapeutics News
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flynn James E
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hamilton Thomas Edward
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Truitt Joseph
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SHERMAN JEFFREY W
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director LEFF JONATHAN S
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMAS FRANK E
Larimar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(33.32%),James E. Flynn(33.32%), etc.
Larimar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.5%),Peter Kolchinsky(9.5%), etc.
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Flynn James E
Larimar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(34.82%),James E. Flynn(34.82%), etc.
Larimar Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Management Company, L.P.(39.20%),James E. Flynn(39.20%), etc.
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director THOMAS FRANK E
Larimar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Blue Owl Capital Holdings LP(7.78%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(0%),Joseph Edelman(0%), etc.
Larimar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Verition Fund Management LLC(6.4%),Nicholas Maounis(6.4%)
Larimar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(6.0%),Janus Henderson Biotech Innovation Master Fund Ltd(6.0%)
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Shankar Gopi
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Celano Michael
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer BEN-MAIMON CAROLE
Larimar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Clayton Russell
Analysis
Price Target
No Data
